Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes 56:1174-1176, 2007
DOI: 10.2337/db06-1555
© 2007 by the American Diabetes Association
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qu, H.-Q.
Right arrow Articles by Polychronakos, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qu, H.-Q.
Right arrow Articles by Polychronakos, C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Brief Report

Toward Further Mapping of the Association Between the IL2RA Locus and Type 1 Diabetes

Hui-Qi Qu1, Alexander Montpetit2, Bing Ge2, Thomas J. Hudson2, and Constantin Polychronakos1

1 Endocrine Genetics Laboratory, McGill University Health Center (Montréal Children's Hospital), Montréal, Québec, Canada
2 McGill University and Genome Québec Innovation Centre, Montréal, Québec, Canada

Address correspondence and reprint requests to Dr. Constantin Polychronakos McGill University Health Center (Montréal Children's Hospital), 2300 Tupper, Montréal, Qc H3H 1P3, Canada. E-mail: constantin.polychronakos{at}mcgill.ca

Abbreviations: IL, interleukin; LD, linkage disequilibrium; SNP, single nucleotide polymorphism


   ABSTRACT
TOP
 ABSTRACT
RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
A novel type 1 diabetes locus was mapped to the interleukin-2 receptor {alpha} gene (IL2RA) on chromosome 10p15.1, encoding an important modulator of immunity. The aim of the current study was to confirm the association of IL2RA with type 1 diabetes and to attempt further mapping of the genetic effect with a new set of 12 single nucleotide polymorphisms (SNPs). We genotyped 949 nuclear family trios with one type 1 diabetes–affected offspring and two parents (2,847 individuals). Two of the 12 IL2RA SNPs genotyped (rs706778 and rs3118470) had statistically significant type 1 diabetes association (P = 6.96 x 10–4 and 8.63 x 10–4, respectively). Both SNPs are located in the 5' end of the long intron 1 within 3 kb of each other and are in high linkage disequilibrium (D' = 0.997, r2 = 0.613). The A-C haplotype (frequency = 0.331) was associated with increased type 1 diabetes risk (P = 3.02 x 10–4). Our study identifies two markers in the IL2RA gene that are significantly associated with type 1 diabetes, supporting IL2RA as a promising candidate gene for type 1 diabetes and suggesting a potential role of IL2R{alpha} in the pathogenesis of type 1 diabetes, likely involving regulatory T-cells.

The interleukin (IL)-2 receptor-{alpha} gene (IL2RA) encodes the {alpha} chain of the IL-2 receptor complex (also known as CD25), an important modulator of immunity (1). IL-2 is a powerful growth factor for both T- and B-cells (2). It acts through a quaternary receptor signaling complex containing {alpha}, ß, and a common {gamma} ({gamma}c, shared by the family of IL receptors) chain (3). Recently, Vella et al. (4) identified a novel type 1 diabetes locus, mapping to IL2RA, whose eight exons extend over 48 kb on chromosome 10p15.1 (supplementary Fig. 1 [available in an online appendix at http://dx.doi.org/10.2337/db06-1555]). Multilocus analysis of data from 20 tag single nucleotide polymorphisms (SNPs) from the 3' and 5' ends of the gene was used in case-control and family-based population samples (4). The large sample sizes (7,457 case and control subjects and 725 multiplex families) substantiated the association with high statistical significance, but further work is needed on this locus. Even though odds ratios (ORs) were calculated for individual SNPs, Vella et al. (4) report the significance of the association with IL2RA only in terms of a multilocus analysis. In addition, analysis of the family-based data was not confined to heterozygous parents, which compromised the protection against population stratification (5).

The aim of the work reported here was to confirm this observation in a new set of 12 SNPs (including 5 tested in ref. 4) and attempt further fine mapping of the genetic effect.


   RESEARCH DESIGN AND METHODS
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Genomic DNA was obtained after informed consent was given, which was approved by the research ethics board of the Montréal Children's Hospital and other participating centers. Ethnic backgrounds were of mixed European descent, with the largest single group being of Québec French-Canadian origin (40% of the total collection). All patients were diagnosed under the age of 18 years and required continuous insulin treatment from the time of diagnosis. The sample consisted of 949 nuclear family trios with one type 1 diabetes–affected offspring and two parents (2,847 individuals).

SNP selection.
In a search for the functional variant, or a better marker for it, we selected 10 tag SNPs from the linkage disequilibrium (LD) blocks in which Vella et al. (4) found multilocus evidence of association. The data of HapMap public release no. 20 was used. Two additional SNPs (rs28360490 and rs706778) were generously suggested to us by C.E. Lowe and J.A. Todd (personal communication) based on their unpublished data. All 12 SNPs are contained in two LD blocks, which are in strong LD with each other (supplementary Fig. 1).

SNP genotyping.
We genotyped 10 SNPs by the Sequenom MassARRAY system and 2 (rs28360490 and rs706778) by an AcycloPrime-FP SNP detection kit (Perkin Elmer, Boston, MA). Rates for genotyping success and Mendelian error are shown in supplementary Table 1. In the 60 European HapMap samples (the parents in the CEU set) genotyped by both us and J.A. Todd's group for rs28360490 and rs706778, concordance was 100%. Our genotyping of rs706778 is also completely concordant with the HapMap data.


View this table:
[in this window]
[in a new window]

  		TABLE 1 Transmission disequilibrium tests of the IL2RA SNPs

 
Statistics.
Transmission disequilibrium test and LD analysis were performed by Haploview software (www.broad.mit.edu/personal/jcbarret/haploview) (6). Haplotypic association was tested by family-based association test software (http://www.biostat.harvard.edu/~fbat/fbat.htm) (7). To maintain a study-wide {alpha} level of 0.05 after testing 12 SNPs, we set the significance threshold for individual SNPs to 0.004, an overly conservative adjustment because, in the presence of LD, SNP genotypes are not independent. The OR was estimated by logistic regression, based on the methods described by Lohmueller et al. (8).


   RESULTS
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Two of the 12 IL2RA SNPs genotyped (rs706778 and rs3118470) had statistically significant type 1 diabetes association (Table 1). Both are located in the 5' end of the long intron 1 within 3 kb of each other, are in high LD (D' = 0.997, r2 = 0.613), and confer similar ORs (Table 1). They map to the second LD block, which encompasses the 5' flanking region, the first exon, and the 5' end of intron 1 of IL2RA.

Of the four possible haplotypes that the two significant SNPs can form, three accounted for 99% of chromosomes in our sample. The G-T haplotype (frequency = 0.551) was associated with a decreased (OR 0.81 [95% CI 0.71–0.92], P = 5.66 x 10–4) and the A-C haplotype (frequency = 0.331) with an increased (1.26 [1.10–1.46], P = 3.02 x 10–4) type 1 diabetes risk. There was no significant type 1 diabetes association with the A-T haplotype (frequency 0.116, P = 0.824), suggesting that the A-C haplotype is the marker for the genetic effect. However, this will need to be confirmed in additional studies because the difference in transmission frequencies between A-T and A-C did not reach statistical significance (P = 0.098).


   DISCUSSION
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
Our study confirms the type 1 diabetes association of the IL2RA locus and identifies two markers for the effect. The biological mechanism of this association is still not apparent. Extensive resequencing of both case and control subjects by Vella et al. (4) revealed no nonsynonymous substitutions occurring at any frequency that could explain the association through protein sequence changes, and there are no known alternative splicing isoforms in which abundance could be affected by the intronic SNPs. In cultured lymphoblastoid cells lines, we found no association between the type 1 diabetes–predisposing haplotype and IL2RA mRNA expression levels (data not shown).

IL2RA maps within the chromosome 10p14-q11 linkage peak identified in the largest study to date (1,435 families) with the second highest logarithm of odds score outside the HLA region (9). It is unlikely that this peak is accounted for by the relatively weak effect we detected, and it may be due to aggregate effects from additional associated loci. However, the intriguing possibility that the IL2RA SNPs are merely markers in weak LD with a much stronger remote effect must be further pursued. As suggested by Vella et al. (4), IL15RA, which maps to a neighboring block in weak LD, is a distinct possibility.

What makes IL2RA a particularly interesting candidate for type 1 diabetes is the recent increase in understanding of the importance of regulatory T-cells in self-tolerance. CD25 is upregulated upon engagement of the T-cell receptor, but a small subset of CD4+ T-cells express it constitutively upon their maturation in the thymus. They constitute the population of CD4+CD25+ regulatory T-cells that are anergic to T-cell receptor signals and potently suppress activated T-cells in a contact-dependent and cytokine-independent fashion (10). This active immune suppression mechanism plays an important role in maintaining immune homeostasis and inhibiting autoimmune disease (11). As direct evidence of the importance of CD4+CD25+ T-cells in type 1 diabetes, the transfer of CD4+CD25+ T-cells can prevent diabetes in recipient NOD mice (12). CD4+CD25+ T-cells depend on IL-2 for their growth and survival, and the IL-2 signaling effect is mainly mediated by IL2R{alpha} (1,13). The two SNPs in the IL2RA gene are significantly associated with type 1 diabetes, supporting IL2RA as a promising candidate gene for type 1 diabetes and suggesting a potential role of IL2R{alpha} in the pathogenesis of type 1 diabetes, likely involving regulatory T-cells. In addition, considering the important role of IL-2 receptor-{alpha} in immune regulation, the association of IL2RA with other autoimmune diseases must also be examined.


   ACKNOWLEDGMENTS
 
This work was funded by the Juvenile Diabetes Research Foundation and Genome Canada through the Ontario Genomics Institute. H.-Q.Q. is supported by a fellowship from the Canadian Institutes of Health Research. T.J.H. is supported by a clinician-scientist award in translational research by the Burroughs Wellcome Fund and an investigator award from the Canadian Institutes of Health Research.

We thank all families who participated in this study and Diane Laforte and her team for their recruiting efforts.


   FOOTNOTES
 
Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db06-1555.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received for publication November 7, 2006 and accepted in revised form December 21, 2006


   REFERENCES
TOP
 ABSTRACT
 RESEARCH DESIGN AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW: Interleukin-2 receptor [alpha] chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521–530, 1995[Medline]
  2. Lowenthal JW, Zubler RH, Nabholz M, MacDonald HR: Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature 315:669–672, 1985[Medline]
  3. Wang X, Rickert M, Garcia KC: Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. Science 310:1159–1163, 2005[Abstract/Free Full Text]
  4. Vella A, Cooper JD, Lowe CE, Walker N, Nutland S, Widmer B, Jones R, Ring SM, McArdle W, Pembrey ME, Strachan DP, Dunger DB, Twells RC, Clayton DG, Todd JA: Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet 76:773–779, 2005[Medline]
  5. Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506–516, 1993[Medline]
  6. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265, 2005[Abstract/Free Full Text]
  7. Horvath S, Xu X, Laird NM: The family based association test method: strategies for studying general genotype–phenotype associations. Eur J Hum Genet 9:301–306, 2001[Medline]
  8. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177–182, 2003[Medline]
  9. Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS: Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 54:2995–3001, 2005[Abstract/Free Full Text]
  10. Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V: Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice. Ann N Y Acad Sci 1051:72–87, 2005[Medline]
  11. Shevach EM: Certified professionals: CD4(+)CD25(+) suppressor T cells. J Exp Med 193:F41–F46, 2001[Free Full Text]
  12. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA: B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440, 2000[Medline]
  13. Randolph DA, Fathman CG: CD4+CD25+ regulatory T cells and their therapeutic potential. Annu Rev Med 57:381–402, 2006[Medline]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
D.-A. Tregouet, P.-H. Groop, S. McGinn, C. Forsblom, S. Hadjadj, M. Marre, H.-H. Parving, L. Tarnow, R. Telgmann, T. Godefroy, et al.
G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes
Diabetes, October 1, 2008; 57(10): 2843 - 2850.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. Butty, C. Campbell, D. Mathis, C. Benoist, and the DPT-1 Study Group
Impact of Diabetes Susceptibility Loci on Progression From Pre-Diabetes to Diabetes in At-Risk Individuals of the Diabetes Prevention Trial-Type 1 (DPT-1)
Diabetes, September 1, 2008; 57(9): 2348 - 2359.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. J. Smyth, J. D. Cooper, J. M.M. Howson, N. M. Walker, V. Plagnol, H. Stevens, D. G. Clayton, and J. A. Todd
PTPN22 Trp620 Explains the Association of Chromosome 1p13 With Type 1 Diabetes and Shows a Statistical Interaction With HLA Class II Genotypes
Diabetes, June 1, 2008; 57(6): 1730 - 1737.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
H. Hakonarson, H.-Q. Qu, J. P. Bradfield, L. Marchand, C. E. Kim, J. T. Glessner, R. Grabs, T. Casalunovo, S. P. Taback, E. C. Frackelton, et al.
A Novel Susceptibility Locus for Type 1 Diabetes on Chr12q13 Identified by a Genome-Wide Association Study
Diabetes, April 1, 2008; 57(4): 1143 - 1146.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qu, H.-Q.
Right arrow Articles by Polychronakos, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qu, H.-Q.
Right arrow Articles by Polychronakos, C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum